Literature DB >> 8783634

Distribution of injected iron 59 and manganese 54 in hypotransferrinemic mice.

T K Dickinson1, A G Devenyi, J R Connor.   

Abstract

Transferrin has been proposed as the mobilization protein for iron and manganese. To better understand the role of transferrin in the transport of these metals, we studied the tissue distribution of injected iron 59 and manganese 54 in the hypotransferrinemic (Hp) mouse mutant. The Hp mouse has a mutation in the transferrin gene and produces < 1% of normal transferrin levels. The tissue distribution of 59Fe and 54Mn in Hp mice was compared with that in animals heterozygous for the Hp mutation (50% transferrin levels) and wild-type animals. Formed elements in the brain, liver, spleen, heart, sternum/rib, plasma, and blood were analyzed for isotope incorporation at 24 hours, 7 days, and 4 weeks after injection. Tissue distribution of both 59Fe and 54Mn was similar in wild-type and heterozygote animals, indicating that decreased transferrin concentration and increased saturation did not influence the tissue distribution of the injected metals. The absence of transferrin in the Hp mutant was associated with abnormal tissue distribution of radiolabeled iron; there was 4 times more 59Fe than normal in the Hp liver and 10 times less 59Fe in the spleen and blood formed elements than normal. Injected manganese also accumulated at abnormally high levels in the Hp mouse liver. Distribution of either metal to the brain, heart, and sternum/rib was not affected by the absence of plasma transferrin. These results reveal that transferrin is required for proper targeting of manganese and iron, especially from the liver to other organs, but further indicate that nontransferrin transport mechanisms for iron and manganese must exist.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783634     DOI: 10.1016/s0022-2143(96)90028-1

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

Review 2.  Known and potential roles of transferrin in iron biology.

Authors:  Thomas Benedict Bartnikas
Journal:  Biometals       Date:  2012-08       Impact factor: 2.949

Review 3.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

Review 4.  The use of hypotransferrinemic mice in studies of iron biology.

Authors:  Julia T Bu; Thomas B Bartnikas
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

5.  Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc.

Authors:  Carolina Herrera; Michael A Pettiglio; Thomas B Bartnikas
Journal:  J Biol Inorg Chem       Date:  2014-02-25       Impact factor: 3.358

Review 6.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

7.  Alteration of iron homeostasis following chronic exposure to manganese in rats.

Authors:  W Zheng; Q Zhao; V Slavkovich; M Aschner; J H Graziano
Journal:  Brain Res       Date:  1999-06-26       Impact factor: 3.252

8.  Profile of altered brain iron acquisition in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Xin-Sheng Wang; Stephanie M Patton; Richard P Allen; Christopher J Earley
Journal:  Brain       Date:  2011-03-11       Impact factor: 13.501

Review 9.  Manganese flux across the blood-brain barrier.

Authors:  Robert A Yokel
Journal:  Neuromolecular Med       Date:  2009-11-10       Impact factor: 3.843

Review 10.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.